BNF for Children 2021-2022: September 2021-22

Product Information

Ceftriaxone [update to include dosing in children from 12 years old for gonococcal conjunctivitis, gonococcal epididymo-orchitis, and disseminated gonococcal infection].

This was an anomaly, [4] as in relation to responses to medicines, the difference between a newborn and a sixteen-year-old is greater than the difference between a sixteen-year-old and a sixty-year-old. Starting in 2002, Prof Martin Kendall, [5] [6] then chairman of the BNF Joint Formulary Committee worked to get things changed. Aronson, J. K. (2004). "Drug interactions-information, education, and the British National Formulary". British Journal of Clinical Pharmacology. 57 (4): 371–372. doi: 10.1111/j.1365-2125.2004.02125.x. PMC 1884473. PMID 15025733. Vaccines update [classifications changed to Vaccines, live or Vaccines, inactivated and non-replicating].Digital Medicines Information Suite". Archived from the original on 19 December 2008 . Retrieved 22 December 2008. MedicinesComplete Drugs that cause hepatotoxicity, drugs with CNS depressant effects, and drugs that increase serum potassium: pharmacodynamic effects drug groups revalidated and updated; see Appendix 1 interactions. COVID-19 vaccine: update to Pfizer/BioNTech vaccine ( Comirnaty®) to include use in children from 6 months old. Valproate: re-analysis of study on risks in children of men taking valproate [MHRA/CHM advice] (advice in sodium valproate, valproic acid; see example in sodium valproate). Drugs that cause first dose hypotension, drugs that cause peripheral neuropathy, and drugs that cause hyponatraemia: pharmacodynamic effects drug groups revalidated and updated; see Appendix 1 interactions.

Clarithromycin [update to include dosing for prevention of invasive group A streptococcal infection in children from 6 months old and adults]. NICE apps for smartphones and tablets". www.nice.org.uk. National Institute for Health and Care Excellence. April 2014. Archived from the original on 13 August 2014 . Retrieved 19 July 2014. Aminoglycosides: pre-treatment screening advice on genetic testing for aminoglycoside exposure posing risk to hearing (advice in relevant monographs; see example in gentamicin). The British National Formulary for Children (BNFC) [1] [20] [21] book, first published September 2005, [2] is published yearly, [2] and details the doses and uses of medicines in children from neonates to adolescents. [1] BNF sections [ edit ] Elias-Jones, A.; Rylance, G. (2005). "The launch of the British National Formulary for Children". Archives of Disease in Childhood. 90 (10): 997–998. doi: 10.1136/adc.2005.080366. PMC 1720111. PMID 16177154.BNF for Children BNFC 2019-2020" (PDF). Archived from the original (PDF) on 11 October 2021 . Retrieved 1 May 2022. chairing the Paediatric Formulary Committee and Dinesh Mehta as the first executive editor. Anne, the Princess Royal attended the launch on 14 July. Vaccines update: restructure of Influenza vaccine monograph—creation of monographs for influenza vaccine (live) and influenza vaccine (inactivated). The British National Formulary is divided into various sections; with the main sections on drugs and preparations being organised by body system.